Product Information
SUMATRIPTAN SUCC 50 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.3231 per EA under NDC 62756052169. Its NADAC has been published 639 times since Nov 28, 2013.
FDA first approved this application on Aug 10, 2009.
Strength
50 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756052169
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA078295FDA Approved
8/10/2009
On Market Since
8/10/2009
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN SUCC 50 MG TABLET has been published 639 times since Nov 28, 2013, and over the history we have for it it has declined 61.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3231 per EA |
|---|---|
| All-time high | $1.0034 (Mar 11, 2015) |
| All-time low | $0.3029 (Nov 20, 2024) |
| 52-week high | $0.3505 |
| 52-week low | $0.3231 |
| Median price | $0.5592 |
| Average price | $0.5886 |
| Largest weekly change | +31.3% (Aug 21, 2024) |
| Weeks tracked | 639 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-4.2%
3Y
-22.2%
5Y
-38.9%
All
-61.4%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sumatriptan succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SUMATRIPTAN SUCC 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN SUCC 50 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.3231 per EA (NDC 62756052169), effective Feb 18, 2026.
How has the price of SUMATRIPTAN SUCC 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN SUCC 50 MG TABLET has declined 61.4%. It has been tracked across 639 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN SUCC 50 MG TABLET?
Since Nov 28, 2013, the NADAC for SUMATRIPTAN SUCC 50 MG TABLET has ranged from a low of $0.3029 (Nov 20, 2024) to a high of $1.0034 (Mar 11, 2015), with a median of $0.5592 per EA.
Are there cheaper alternatives to SUMATRIPTAN SUCC 50 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUMATRIPTAN SUCC 50 MG TABLET, is $0.3022 per EA — about 6% below SUMATRIPTAN SUCC 50 MG TABLET.
Who manufactures SUMATRIPTAN SUCC 50 MG TABLET?
SUMATRIPTAN SUCC 50 MG TABLET (NDC 62756052169) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.